Phase IIIB Switching From Intravenous to Subcutaneous Study
NCT00663702
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Arthritis, Rheumatoid
Interventions
DRUG:
Abatacept
Sponsor
Bristol-Myers Squibb